Published in CMAJ on December 12, 2011
Treatment variation in stent choice in patients with stable or unstable coronary artery disease. Neth Heart J (2016) 1.02
Determinants of variations in initial treatment strategies for stable ischemic heart disease. CMAJ (2015) 0.82
The Effect of Geographic Units of Analysis on Measuring Geographic Variation in Medical Services Utilization. J Prev Med Public Health (2016) 0.79
Comparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based study. J Gen Intern Med (2014) 0.79
Relation between initial treatment strategy in stable coronary artery disease and 1-year costs in Ontario: a population-based cohort study. CMAJ Open (2016) 0.75
Revascularization options: one size does not fit all. CMAJ (2011) 0.75
Evaluation of Geographic Indices Describing Health Care Utilization. J Prev Med Public Health (2017) 0.75
Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program. J Am Heart Assoc (2017) 0.75
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet (2003) 19.90
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet (1994) 11.37
Impracticability of informed consent in the Registry of the Canadian Stroke Network. N Engl J Med (2004) 9.85
Guidelines on myocardial revascularization. Eur Heart J (2010) 8.85
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med (2008) 6.77
Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med (2005) 6.53
Grey zones of clinical practice: some limits to evidence-based medicine. Lancet (1995) 6.15
Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med (2007) 3.10
Coronary revascularization trends in the United States, 2001-2008. JAMA (2011) 2.81
Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med (2000) 2.21
An introduction to multilevel regression models. Can J Public Health (2001) 2.11
Temporal trends in the use of percutaneous coronary intervention and coronary artery bypass surgery in New York State and Ontario. Circulation (2010) 1.82
Effect of specialty and nationality on panel judgments of the appropriateness of coronary revascularization: a pilot study. Med Care (2001) 1.44
Increasing rates of angioplasty versus bypass surgery in Canada, 1994-2005. Am Heart J (2010) 1.24
Putting ad hoc PCI on pause. JAMA (2010) 1.20
Informed consent for interventions in stable coronary artery disease: problems, etiologies, and solutions. Eur J Cardiothorac Surg (2010) 0.99
Variations in clinical decision-making between cardiologists and cardiac surgeons; a case for management by multidisciplinary teams? J Cardiothorac Surg (2006) 0.99
Revascularization use and survival outcomes after cardiac catheterization in British Columbia and Alberta. Can J Cardiol (2004) 0.97
Estimating the number of coronary artery bypass graft and percutaneous coronary intervention procedures in Canada: a comparison of cardiac registry and Canadian Institute for Health Information data sources. Can J Cardiol (2010) 0.93
Differences in per capita rates of revascularization and in choice of revascularization procedure for eleven states. BMC Health Serv Res (2006) 0.92
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Mammographic density and the risk and detection of breast cancer. N Engl J Med (2007) 14.32
Impracticability of informed consent in the Registry of the Canadian Stroke Network. N Engl J Med (2004) 9.85
Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med (2015) 7.83
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ (2009) 6.21
Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med (2009) 6.18
Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol (2010) 5.09
Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med (2009) 4.83
Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation (2006) 4.35
A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. N Engl J Med (2004) 4.07
Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation (2014) 3.78
Assessing the association of appropriateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease. J Am Coll Cardiol (2012) 3.45
Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA (2009) 3.08
Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol (2010) 3.07
Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ (2014) 3.06
Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA (2005) 3.05
National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004. CMAJ (2009) 2.89
Use of fibrates in the United States and Canada. JAMA (2011) 2.82
The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol (2004) 2.78
Modeling the cardiac surgery workforce in Canada. Ann Thorac Surg (2010) 2.61
Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation (2007) 2.59
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med (2007) 2.50
Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. JAMA (2012) 2.47
Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 2.44
Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial. Circulation (2007) 2.39
Skeletonization of bilateral internal thoracic artery grafts lowers the risk of sternal infection in patients with diabetes. J Thorac Cardiovasc Surg (2003) 2.39
LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated. Nucleic Acids Res (2008) 2.38
A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts. J Thorac Cardiovasc Surg (2006) 2.35
Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J Virol (2009) 2.35
The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol (2003) 2.34
Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta (2007) 2.31
Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol (2009) 2.23
Carpentier-Edwards Perimount Magna valve versus Medtronic Hancock II: a matched hemodynamic comparison. Ann Thorac Surg (2007) 2.22
Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest (2003) 2.21
Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med (2010) 2.20
HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase. PLoS Pathog (2007) 2.13
Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog (2010) 2.12
Prevalence and extent of obstructive coronary artery disease among patients undergoing elective coronary catheterization in New York State and Ontario. JAMA (2013) 2.03
Use of niacin in the United States and Canada. JAMA Intern Med (2013) 2.02
Long-term trends in use of and expenditures for cardiovascular medications in Canada. CMAJ (2009) 2.02
Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy. Arch Intern Med (2011) 1.97
Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail (2012) 1.92
Use of ezetimibe in the United States and Canada. N Engl J Med (2008) 1.85
Temporal trends in the use of percutaneous coronary intervention and coronary artery bypass surgery in New York State and Ontario. Circulation (2010) 1.82
Radial artery access as a predictor of increased radiation exposure during a diagnostic cardiac catheterization procedure. JACC Cardiovasc Interv (2011) 1.78
Clinical outcomes after separate and composite replacement of the aortic valve and ascending aorta. J Thorac Cardiovasc Surg (2004) 1.71
Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study. Circulation (2012) 1.67
Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention. Am J Cardiol (2010) 1.66
Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. J Virol (2007) 1.66
Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest. PLoS Pathog (2010) 1.65
HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration. J Neurosci (2007) 1.64
HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood (2009) 1.63
Factors explaining the under-use of reperfusion therapy among ideal patients with ST-segment elevation myocardial infarction. Eur Heart J (2006) 1.62
Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med (2010) 1.62
Redo valvular surgery in elderly patients. Ann Thorac Surg (2009) 1.61
Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes. Arch Intern Med (2007) 1.59
TPA use for stroke in the Registry of the Canadian Stroke Network. Can J Neurol Sci (2005) 1.58
Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J (2007) 1.58
Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol (2007) 1.56
Relationship between preventability of death after coronary artery bypass graft surgery and all-cause risk-adjusted mortality rates. Circulation (2008) 1.56
Long-term results of aortic valve-sparing operations for aortic root aneurysm. J Thorac Cardiovasc Surg (2006) 1.51
The impact of diabetic status on coronary artery bypass graft patency: insights from the radial artery patency study. Circulation (2008) 1.51
Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings. J Med Econ (2013) 1.48
Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology (2007) 1.48
Indicators of quality of care for patients with acute myocardial infarction. CMAJ (2008) 1.46
Surgical fellowship training in Canada: what is its current status and is improvement required? Can J Surg (2012) 1.45
Dietary measures and exercise training contribute to improvement of endothelial function and atherosclerosis even in patients given intensive pharmacologic therapy. J Cardiopulm Rehabil (2006) 1.44
Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. JACC Cardiovasc Interv (2010) 1.43
Pulsatile versus nonpulsatile cardiopulmonary bypass flow: an evidence-based approach. J Card Surg (2006) 1.43
Family history, mammographic density, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.42
Relationship between initial treatment strategy and quality of life in patients with coronary chronic total occlusions. EuroIntervention (2014) 1.41
Impact of routine in-hospital assessment of low-density lipoprotein levels and standardized orders on statin therapy in patients undergoing percutaneous coronary interventions. J Invasive Cardiol (2005) 1.40
MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. FASEB J (2010) 1.39
Donor pretreatment with hypertonic saline attenuates primary allograft dysfunction: a pilot study in a porcine model. Circulation (2009) 1.39
Economic evaluation of percutaneous left atrial appendage occlusion, dabigatran, and warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. Circulation (2013) 1.35
The cardiac surgery workforce: a survey of recent graduates of Canadian training programs. Ann Thorac Surg (2010) 1.35
Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol (2012) 1.34
Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells. J Biol Chem (2003) 1.33
Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med (2013) 1.28
Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. JAMA (2013) 1.28
Intraoperative transesophageal echocardiography accurately predicts mitral valve anatomy and suitability for repair. J Am Soc Echocardiogr (2002) 1.27